MedPath

Sensation of the face in patients with unilateral facial nerve palsy

Recruiting
Conditions
facial nerve palsy
facial paralysis
10011305
Registration Number
NL-OMON53450
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
63
Inclusion Criteria

Group 1 (new onset facial palsy patients):
- 18 years or older, and;
- (A history of) unilateral facial nerve palsy, independent of etiology

Group 2A/B (facial synkinesis/hemifacial spasms patients):
- 18 years or older, and;
- (A history of) unilateral facial nerve palsy, independent of etiology, and;
- >=1 year after the start of the facial nerve palsy, or;
- Hemifacial spasms caused by a neurovascular conflict

Exclusion Criteria

Group 1:
- First presentation longer than 3 weeks after onset of facial nerve palsy
(relative exclusion criterium, this is not the case for patients with
synkinesis)
- Bilateral facial nerve palsy

Group 2A/B:
- (A history of) bilateral facial nerve palsy

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- To evaluate sensation of the face in patients with unilateral facial nerve<br /><br>palsy and compare the sensation of the affected side to the non-affected side.<br /><br>- To compare sensation of the face in patients with synkinesis after facial<br /><br>nerve palsy to patients with hemifacial spasms due to a neurovascular conflict.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- To evaluate the change in sensation of the face at the beginning and during<br /><br>recovery of facial nerve palsy.<br /><br>- To measure quality of life by use of the FACE-Q Paralysis scale in patients<br /><br>with unilateral facial nerve palsy.<br /><br>- To investigate whether a correlation exists between sensation of the face and<br /><br>course of the facial palsy in time.</p><br>
© Copyright 2025. All Rights Reserved by MedPath